Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Progranulin and cholangiocarcinoma: another bad boy on the block!
Alvaro D.
Gut. 2012 Feb;61(2):170-1. Epub 2011 Nov 7. No abstract available.
Related citations
Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism.
Frampton G, Invernizzi P, Bernuzzi F, Pae HY, Quinn M, Horvat D, Galindo C, Huang L, McMillin M, Cooper B, Rimassa L, DeMorrow S.
Gut. 2012 Feb;61(2):268-77. Epub 2011 Nov 7.
Immune reactivity to β-tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders.
Op De Beéck K, Van den Bergh K, Vermeire S, Decock S, Derua R, Waelkens E, Rutgeerts P, Nevens F, Bossuyt X.
Gut. 2011 Nov;60(11):1601-2. Epub 2010 Dec 15. No abstract available.
Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma.
Francis H, DeMorrow S, Venter J, Onori P, White M, Gaudio E, Francis T, Greene JF Jr, Tran S, Meininger CJ, Alpini G.
Gut. 2012 May;61(5):753-64. Epub 2011 Aug 26.
Pregnancy in primary sclerosing cholangitis.
Gossard A, Lindor K.
Gut. 2011 Aug;60(8):1027-8. Epub 2011 May 11. No abstract available.
PSC: Protect and serve with colitis: does it help the liver to have severe ulcerative colitis?
Rust C, Brand S.
Gut. 2011 Sep;60(9):1165-6. Epub 2011 May 11. No abstract available.
Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
Marelli L, Xirouchakis E, Kalambokis G, Cholongitas E, Hamilton MI, Burroughs AK.
Gut. 2011 Sep;60(9):1224-8. Epub 2011 Mar 14.
Wellge BE, Sterneck M, Teufel A, Rust C, Franke A, Schreiber S, Berg T, Günther R, Kreisel W, Zu Eulenburg C, Braun F, Beuers U, Galle PR, Lohse AW, Schramm C.
Gut. 2011 Aug;60(8):1117-21. Epub 2011 Feb 21.
Portal cholangiopathy: radiological classification and natural history.
Llop E, de Juan C, Seijo S, García-Criado A, Abraldes JG, Bosch J, García-Pagán JC.
Gut. 2011 Jun;60(6):853-60. Epub 2011 Jan 26.
A patient with biliary colic and intestinal obstruction.
van der Spek BW, Cuesta MA, Jacobs MA.
Gut. 2012 May;61(5):713, 752. Epub 2010 Dec 29. No abstract available.
A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus.
Goldman A, Shahidullah M, Goldman D, Khailova L, Watts G, Delamere N, Dvorak K.
Gut. 2010 Dec;59(12):1606-16. Epub 2010 Sep 28.
When to leave a stone unturned ...
von Rosenvinge EC, Koh C, Holland SM, Heller T.
Gut. 2010 Aug;59(8):1036, 1100. Epub 2010 Jun 10. No abstract available.
Conditional Gata4 deletion in mice induces bile acid absorption in the proximal small intestine.
Beuling E, Kerkhof IM, Nicksa GA, Giuffrida MJ, Haywood J, aan de Kerk DJ, Piaseckyj CM, Pu WT, Buchmiller TL, Dawson PA, Krasinski SD.
Gut. 2010 Jul;59(7):888-95.
Patients with m2 antibodies: what diagnosis and follow-up are they given?
Byrne EA, Katbamna R, Scott C, Blanshard C, Marley R, Coppack SW, Foster GR.
Gut. 2010 Jun;59(6):859; author reply 859-60. No abstract available.
p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ.
Terjung B, Söhne J, Lechtenberg B, Gottwein J, Muennich M, Herzog V, Mähler M, Sauerbruch T, Spengler U.
Gut. 2010 Jun;59(6):808-16. Epub 2009 Dec 1.
The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis.
Albillos A, Nieto M, Ubeda M, Muñoz L, Fraile B, Reyes E, Lledó L, Blanco I, Pastor O, Salas C, Lario M, Monserrat J, Bataller R, Alvarez-Mon M.
Gut. 2010 Jul;59(7):943-52. Epub 2010 May 4.
From kitchen to gut: curcumin in cholestasis.
Safadi R.
Gut. 2010 May;59(5):565-6. No abstract available.
Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.
Baghdasaryan A, Claudel T, Kosters A, Gumhold J, Silbert D, Thüringer A, Leski K, Fickert P, Karpen SJ, Trauner M.
Gut. 2010 Apr;59(4):521-30.
Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations.
Prince MI, Ducker SJ, James OF.
Gut. 2010 Apr;59(4):508-12.
Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease.
Akitake R, Watanabe T, Zaima C, Uza N, Ida H, Tada S, Nishida N, Chiba T.
Gut. 2010 Apr;59(4):542-5.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on